¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2022-06-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2022-06-24
±³À°ÀÏÀÚ : 2022-06-24
±³À°Àå¼Ò : ºÎ»ê ½Ã±×´Ï¿¤ ±×·£µåº¼·ë(4F)  
±³À°ÁÖÁ¦ : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¤ÀºÇý
¿¬¶ôó : 02-582-8212  
À̸ÞÀÏ : grace@kscvi.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 13 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í - Àü¹®ÀÇ,°³¿øÀÇ,ÀϹÝÀÇ:(ÇöÀåµî·Ï)60,000¿ø - ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç,ÀÇ·á±â»ç,ÀÇ´ë»ý,±ºÀÇ°ü,°øÁߺ¸°ÇÀÇ,ÀÓ»óº´¸®»ç,Àǹ«±â·Ï»ç:(ÇöÀåµî·Ï)50,000¿ø - »ê¾÷ü,±âŸ:(ÇöÀåµî·Ï)120,000¿ø - ÇÐȸ Á¤È¸¿ø(Àü³âµµ ȸºñ¿Ï³³ÀÚ): ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-24 Main Arena 10:30~10:40 Anti-platelet Strategies in NSTE ACS(Non-ST Elevation-Acute Coronary Syndrome), Which and When?  ±èÇö±¹(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 10:40~10:50 Timing of Invasive Coronary Angiography in NSTE ACS(Non-ST Elevation-Acute Coronary Syndrome), When and Whom?  ÀÌ¿øÀç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 10:50~11:00 PCI(Percutaneous Coronary Intervention) vs. CABG(Coronary Artery Bypass Grafting), Finding Dividing Lines  ÃÖ±âÈ«(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 11:00~11:10 Long-term Management of NSTE ACS(Non-ST Elevation-Acute Coronary Syndrome), Focused on Lifestyle Management  ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 06-24 Main Arena 11:10~11:30 Discussion  () 
±³À°½Ã°£ 06-24 Symposium Arena 10:30~10:40 I Prefer to the Short-duration Strategy  ±èµ¿ºó(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 10:40~10:50 I Prefer to the De-escalation Strategy  Á¤¿µÈÆ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 10:50~11:00 I Prefer to the Prasugrel-based De-escalation  °­Å¼ö(´Ü±¹ÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 11:00~11:10 I Prefer to the Ticagrelol-based De-escalation  ¾È¼º±Õ(¿¬¼¼¿øÁÖÀÇ´ë) 
Åä·Ð 06-24 Symposium Arena 11:10~11:30 Discussion  () 
±³À°½Ã°£ 06-24 Main Arena 11:40~11:50 ¿µ»óÀ¯ÇüÀÇ ÁßÀç½Ã¼ú¿µ¿ªÀ» ½Ã¼úÀ¯ÇüÀ¸·Î µ¶¸³ÇϱâÀ§ÇÑ Áغñ  Á¶´ö±Ô(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 11:50~12:00 ½Ã¼úÀ¯ÇüÀÇ ½Å¼³ÀÇ °¡´É¼º ¹× ¹æÇâ  Àü·Î¿ø(Àü·Î¿ø ³»°ú,´ëÇѳ»°úÇÐȸ »ó´ë°¡Ä¡À§¿øÀå) 
Åä·Ð 06-24 Main Arena 12:00~12:10 Discussion  () 
±³À°½Ã°£ 06-24 Main Arena 12:10~12:20 ½ÉÇ÷°üÁßÀçÀÇ»çÀÇ ÀÔÀå¿¡¼­ º» ¹®Á¦Á¡°ú ÇØ°á¹æ¾È  ÃÖ±âÈ«(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 12:20~12:30 °æÇèÀû »ç·Ê °íÂû ¹× ÀüÇâÀû ÇØ°á¹æ¾È  ±è±¹Èñ(°Ç°­º¸Çè½É»çÆò°¡¿ø,¾àÁ¦°ü¸®½Ç ¾àÁ¦±âÁغÎÀå) 
Åä·Ð 06-24 Main Arena 12:30~12:40 Discussion  () 
±³À°½Ã°£ 06-24 Symposium Arena 11:40~11:52 Pro: Distal Radial Access Should Be the First Access Site for Coronary Intervention  À̺À±â(°­¿øÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 11:52~12:04 Cons: Radial Access Is Enough for the First Access Site for Coronary Intervention  À¯»ó¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 12:04~12:16 Cons: No, Femoral Access Should Be the First Access Site for Coronary Intervention  ±è¼öÁß(°æÈñÀÇ´ë) 
Åä·Ð 06-24 Symposium Arena 12:16~12:40 Discussion  () 
±³À°½Ã°£ 06-24 Symposium Arena 12:50~13:05 Dual Pathway Inhibition for Antithrombotic Prevention in CV Disease(Cardiovascular Disease)  ±Ç¿À¼º(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 13:05~13:20 Pre-treatment with Oral P2Y12 Inhibitor in ACS(Acute Coronary Syndrome) Patients: Focused on Clopidogrel  ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 13:20~13:35 Which Strategy Is the Best following 1-year DAPT(Dual Antiplatelet Therapy)?: Deep Dive into the HOST-EXAM Trial  °­ÁöÈÆ(¼­¿ïÀÇ´ë) 
Åä·Ð 06-24 Symposium Arena 13:35~13:50 Discussion  () 
±³À°½Ã°£ 06-24 Main Arena 14:00~14:09 AMI(Acute Myocardial Infarction) ÀÀ±Þ½Ç ³»¿ø½Ã°£ ´ÜÃà, ½Ã¼ú ÈÄ Ä¡·á¼øÀÀµµ, ¾î¶»°Ô °³¼±ÇÒ±î?  ¼­Á¸(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 14:09~14:18 Ç÷°üÁßÀç½Ã¼ú °ü·Ã ¹æ»ç¼± ¾ÈÀü°ü¸® ±Ç°í¾È 2022  ±è¼ºÀº(ÇѸ²ÀÇ´ë) 
Åä·Ð 06-24 Main Arena 14:18~14:28 Discussion  () 
±³À°½Ã°£ 06-24 Main Arena 14:28~14:37 ÀÀ±Þ½Ã¼ú ¿ÂÄÝ´ë±â ¼ö´ç, ¾î¶»°Ô ÇØ¾ß ÇÒ±î?  ¹Úâ¹ü(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 14:37~14:50 ÀÇ·áºÐÀï, ¾î¶»°Ô ´ëºñÇØ¾ß Çϳª? - ÃֽŠÆÇ·Ê Á߽ɠ À̵¿ÇÊ(¹ý¹«¹ýÀÎ ÀǼº) 
Åä·Ð 06-24 Main Arena 14:50~15:00 Discussion  () 
±³À°½Ã°£ 06-24 Symposium Arena 14:00~14:10 Detection and Prediction of Future ACS(Acute Coronary Syndrome)-causing Culprit Lesion by Coronary CT(Computed Tomography) Angiography  ÀÌ»óÀº(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 14:10~14:20 Relationship between Clinical Outcomes and Vulnerable Plaque Features Assessed by IVUS(Intravascular Ultrasonography)  ¿øÈ£¿¬(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 14:20~14:30 Comparison of Clinical Outcomes between FFR(Fractional Flow Reserve) guided- and IVUS(Intravascular Ultrasonography) Guided PCI(Percutaneous Coronary Intervention)  °­ÁöÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 14:30~14:40 OCT(Optical Coherence Tomography) Guided Precision PCI(Percutaneous Coronary Intervention): Standard Care from Baseline to Post-stenting  À̽·ü(¿ø±¤ÀÇ´ë) 
Åä·Ð 06-24 Symposium Arena 14:40~15:00 Discussion  () 
±³À°½Ã°£ 06-24 Main Arena 15:10~15:20 TAVR(Transcatheter Aortic Valve Replacement) in Young Age - Pro  ¹Ú´ö¿ì(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 15:20~15:30 TAVR(Transcatheter Aortic Valve Replacement) in Young Age - Cons  ÀÌ»è(¿¬¼¼ÀÇ´ë) 
Åä·Ð 06-24 Main Arena 15:30~15:40 Discussion  () 
±³À°½Ã°£ 06-24 Main Arena 15:40~15:50 TAVR(Transcatheter Aortic Valve Replacement) Is Better with Small Annulus  ÇÑÁ¤±Ô(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 15:50~16:00 SAVR(Surgical Aortic Valve Replacement) Is Better with Small Annulus  À¯Àç¼®(¿ï»êÀÇ´ë) 
Åä·Ð 06-24 Main Arena 16:00~16:10 Discussion  () 
±³À°½Ã°£ 06-24 Symposium Arena 15:10~15:25 Physiology-guided PCI(Percutaneous Coronary Intervention) Optimization  ÀÌÀåÈÆ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 15:25~15:40 Nonhyperemic Pressure Ratios: Are They All the Same?  ÀåÈ£ÁØ(ºÎõ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 06-24 Symposium Arena 15:40~15:55 Coronary Evaluation in Patients with Severe Aortic Stenosis: FFR(Fractional Flow Reserve) vs. iFR(Instantaneous Flow Ratio)?  ÀÌÁÖ¸í(¼º±Õ°üÀÇ´ë) 
Åä·Ð 06-24 Symposium Arena 15:55~16:10 Discussion  () 
±³À°½Ã°£ 06-24 Main Arena 16:20~16:35 ECMO(Extracorporeal Membrane Oxygenation) in AMI(Acute Myocardial Infarction) Complicated by Cardiogenic Shock: Interventional Cardiologist  ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 16:35~16:50 Beyond ECMO(Extracorporeal Membrane Oxygenation) in AMI(Acute Myocardial Infarcti Complicating Cardiogenic Shock: Cardiac Surgeon  Á¤Àç½Â(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 16:50~17:05 Heart Team Approach in Complex Aortic Disease  ·ù»ó¿Ï(ÀÌÈ­ÀÇ´ë) 
Åä·Ð 06-24 Main Arena 17:05~17:20 Discussion  () 
±³À°½Ã°£ 06-24 Symposium Arena 16:20~16:30 When We Meet Invisible or Too Tortous Channels  È²º´Èñ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 16:30~16:40 Difficult Re-entry in rCART(reverse Controlled Antegrade and Retrograde Tracking)  À¯Ã¶¿õ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 16:40~16:50 Challenges with Wire Externalization  ¿øÈ£¿¬(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 06-24 Symposium Arena 16:50~17:00 Problems at Donor Vessel during Intervention  ÀÌÁßÈñ(¿¬¼¼¿øÁÖÀÇ´ë) 
Åä·Ð 06-24 Symposium Arena 17:00~17:20 Discussion  () 
±³À°½Ã°£ 06-24 Main Arena 17:30~17:40 How to Do CTO(Chronic Total Occlusion) in Japan? - Review Japanese Algorithm  Yasuhiro Nakano(Kyushu University Hospital. Japan) 
±³À°½Ã°£ 06-24 Main Arena 17:40~17:50 How to Do CTO(Chronic Total Occlusion) in Korea? - Korean Style  ÀÌÁßÈñ(¿øÁÖ¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-24 Main Arena 17:50~18:00 Where Are We and What Is the Future Perspective of CTO(Chronic Total Occlusion) in Japan?  Atsunori Okamura(Sakurabashi Watanabe Hospital.Japan) 
±³À°½Ã°£ 06-24 Main Arena 18:00~18:10 What Is the Evidence of CTO(Chronic Total Occlusion) in Korea? - Literature Review  Á¶À翵(¿ø±¤ÀÇ´ë) 
Åä·Ð 06-24 Main Arena 18:10~18:30 Discussion  () 
±³À°½Ã°£ 06-24 Symposium Arena 17:30~17:45 Concomitant Transcatheter Treatment for Severe Combined Aortic Stenosis and Acute Mitral Regrugitation  ÀÌÁøÈ£(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 06-24 Symposium Arena 17:45~18:00 Percutaneous Transabdominal Approach for the Treatment of Type II Endoleak after Endovascular Repair of Infrarenal Abdominal Aortic Aneurysm  ±èÇü¼ö(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 06-24 Symposium Arena 18:00~18:15 A Case of Successful Consecutive Trans-catheter Aortic Valve Implantation, Endovascular Repair after PCI(Percutaneous Coronary Intervention) of Severe Symptomatic Aortic Stenosis, Huge AAA(Abdominal Aortic Aneurysm) and Stable Angina  À±¿ø½Ä(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 06-24 Symposium Arena 18:15~18:30 Role of Invasive Hemodyamic Assessment including Exercise Right Heart Catheterization in Patients with HCMP(Hypertrophic Cardiomyopathy)  Á¶Çö½Â(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2022-06-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °í·Á´ëÇб³±¸·Îº´¿ø È£Èí±â³»°ú ÄÚȣƮ °£´ãȸ : 2022-06-24
´ÙÀ½±Û Ãæ³²´ëÇб³º´¿ø ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2022 Åõ¾î½ÉÆ÷Áö¾ö : 2022-06-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 11 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 16 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 19 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 16 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 11 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 7 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 3 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 5 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 5 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 6 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 3 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 12 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 4 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 8 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 7 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷